Metropolitan Life Insurance Company (MetLife)’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,388
| Closed | -$53.4K | – | 2160 |
|
|
2024
Q1 | $53.4K | Hold |
3,388
| – | – | ﹤0.01% | 1372 |
|
|
2023
Q4 | $51.3K | Hold |
3,388
| – | – | ﹤0.01% | 1435 |
|
|
2023
Q3 | $68K | Buy |
3,388
+703
| +26% | +$14.1K | ﹤0.01% | 1228 |
|
|
2023
Q2 | $75.7K | Buy |
2,685
+163
| +6% | +$4.6K | ﹤0.01% | 1175 |
|
|
2023
Q1 | $43.4K | Sell |
2,522
-306
| -11% | -$5.26K | ﹤0.01% | 1469 |
|
|
2022
Q4 | $57K | Hold |
2,828
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q3 | $61.3K | Buy |
2,828
+550
| +24% | +$11.9K | ﹤0.01% | 1321 |
|
|
2022
Q2 | $64K | Hold |
2,278
| – | – | ﹤0.01% | 1333 |
|
|
2022
Q1 | $105K | Sell |
2,278
-7,139
| -76% | -$329K | ﹤0.01% | 1161 |
|
|
2021
Q4 | $792K | Hold |
9,417
| – | – | 0.01% | 1131 |
|
|
2021
Q3 | $628K | Buy |
9,417
+908
| +11% | +$60.5K | 0.01% | 1298 |
|
|
2021
Q2 | $453K | Buy |
8,509
+230
| +3% | +$12.2K | 0.01% | 1582 |
|
|
2021
Q1 | $359K | Hold |
8,279
| – | – | 0.01% | 1619 |
|
|
2020
Q4 | $430K | Buy |
8,279
+4,774
| +136% | +$248K | 0.01% | 1456 |
|
|
2020
Q3 | $115K | Hold |
3,505
| – | – | ﹤0.01% | 2142 |
|
|
2020
Q2 | $168K | Buy |
+3,505
| New | +$168K | ﹤0.01% | 1921 |
|